Prohormone convertases PC1 and PC2 are the essential enzymes that cut inactive peptide precursors into their active forms, and they follow distinctly different activation pathways within the cell.
2 master enzymes for peptide activationPC1 and PC2 are responsible for processing virtually all neuroendocrine peptide precursors into their biologically active forms
What the researchers found
PC1 and PC2 follow markedly different activation pathways. PC1 undergoes rapid propeptide cleavage in the endoplasmic reticulum and is further activated by a carboxyl-terminal processing event. PC2, by contrast, has much longer folding times, exits the ER without propeptide cleavage, and requires association with the neuroendocrine-specific protein 7B2 to become catalytically active.
The 7B2 protein is internally cleaved into a 21-kDa fragment and a 31-residue carboxy-terminal peptide once the complex reaches the trans-Golgi network. PC2 propeptide removal occurs later in secretory granules, likely through autocatalysis, but without prior 7B2 encounter, PC2 cannot generate an active enzyme. A 36-residue internal segment of 7B2 appears to mediate the critical conformational changes.
Why it matters
PC1 and PC2 are the master switches for peptide hormone activation. They process proinsulin into insulin, POMC into endorphins and ACTH, and hundreds of other prohormones into their active forms. Mutations or dysfunction in these enzymes cause severe hormonal disorders including obesity, diabetes, and adrenal insufficiency. Understanding their biology is essential for both basic peptide science and developing therapies that target the peptide processing machinery.
The numbers in context
PC1: rapid ER propeptide cleavage + C-terminal activation; PC2: slow folding, requires 7B2, propeptide removal in secretory granules; 7B2 cleaved into 21-kDa + 31-residue fragments
How the study worked
Narrative review of published cell biology, biochemistry, and molecular biology research on PC1 and PC2 prohormone convertases in neuroendocrine cells.
Who was studied
Not applicable — review article covering cell biology research (primarily from cell culture and animal model studies)
What this study cannot tell us
Review from 1999; some mechanisms described as unknown have since been clarified. Does not cover subsequently identified prohormone convertases or regulatory pathways.
How to read the evidence
This is a comprehensive narrative review synthesizing the state of knowledge about PC1 and PC2 cell biology as of 1999. It's a reference-grade summary of established biochemistry rather than a primary research study with novel findings.
When this study was published
Published in 1999, this is a foundational review that remains relevant for understanding core PC1/PC2 biology. While specific molecular details have been updated by subsequent research, the fundamental cell biology described here is still accurate and widely cited.
The bigger picture
This review provides foundational knowledge for the entire peptide therapeutics field. Every time a cell produces insulin, growth hormone, endorphins, or any other peptide hormone, PC1 and PC2 are doing the processing work. Understanding these enzymes informs drug development for diabetes, obesity, pain, and neuroendocrine tumors — and helps explain why some genetic mutations cause devastating hormonal diseases.
Questions still open
- Can targeting PC1 or PC2 activity be used to modulate peptide hormone levels for therapeutic purposes?
- What happens in diseases where PC1 or PC2 are mutated, and can these defects be corrected?
- Could the 7B2 protein's role in PC2 activation be exploited to selectively regulate specific peptide hormone processing?
Common questions
What do prohormone convertases actually do?
What happens if PC1 or PC2 don't work properly?
Read the original research
The cell biology of the prohormone convertases PC1 and PC2.
Progress in nucleic acid research and molecular biology, 63, 69-108
Citation
Muller, L; Lindberg, I. (1999). The cell biology of the prohormone convertases PC1 and PC2.. Progress in nucleic acid research and molecular biology, 63, 69-108.